The pill, marketed by Gilead as Truvada, contains a combination of the two anti-HIV drugs emtricitabine and tenofovir disoproxil fumarate. Truvada was approved by the U.S. Food and Drug Administration for PrEP in 2012. Typically, the pill is taken daily.
HEALTH DAILY NEWS
Health News, Medical News, Medical conditions, Medical Tests & Procedures, Symptoms, Medical Diagnosis , Health Information, FDA alerts, Drug Watch, Product Watch, Medicine Articles, Welfare, Living